Bessemer Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,939
Closed -$589K 1860
2019
Q3
$589K Sell
5,939
-928
-14% -$88.2K ﹤0.01% 836
2019
Q2
$635K Sell
6,867
-2,058
-23% -$195K ﹤0.01% 818
2019
Q1
$842K Sell
8,925
-882
-9% -$77.1K ﹤0.01% 677
2018
Q4
$629K Sell
9,807
-6,534
-40% -$482K ﹤0.01% 696
2018
Q3
$1.46M Buy
16,341
+1,211
+8% +$107K 0.01% 493
2018
Q2
$1.2M Sell
15,130
-2,176
-13% -$181K ﹤0.01% 533
2018
Q1
$1.54M Buy
17,306
+734
+4% +$70.5K 0.01% 468
2017
Q4
$1.73M Buy
16,572
+674
+4% +$76.1K 0.01% 450
2017
Q3
$2.32M Sell
15,898
-1,074
-6% -$146K 0.01% 417
2017
Q2
$2.21M Buy
16,972
+5,359
+46% +$657K 0.01% 434
2017
Q1
$1.45M Buy
11,613
+271
+2% +$32.4K 0.01% 599
2016
Q4
$1.31M Sell
11,342
-2,435
-18% -$271K 0.01% 636
2016
Q3
$1.44M Sell
13,777
-3,115
-18% -$337K 0.01% 530
2016
Q2
$1.67M Buy
16,892
+485
+3% +$50.2K 0.01% 410
2016
Q1
$1.64M Sell
16,407
-14,552
-47% -$1.5M 0.01% 411
2015
Q4
$3.71M Buy
30,959
+3,197
+12% +$370K 0.02% 308
2015
Q3
$3M Buy
27,762
+18,169
+189% +$2.25M 0.02% 344
2015
Q2
$1.11M Sell
9,593
-2,192
-19% -$251K 0.01% 525
2015
Q1
$1.36M Buy
11,785
+3,976
+51% +$475K 0.01% 474
2014
Q4
$873K Buy
7,809
+2,055
+36% +$217K ﹤0.01% 502
2014
Q3
$546K Buy
5,754
+354
+7% +$31.9K ﹤0.01% 568
2014
Q2
$464K Sell
5,400
-4,410
-45% -$335K ﹤0.01% 586
2014
Q1
$683K Buy
9,810
+40
+0.4% +$3.17K ﹤0.01% 490
2013
Q4
$826K Buy
9,770
+664
+7% +$52.5K 0.01% 462
2013
Q3
$703K Sell
9,106
-1,920
-17% -$135K 0.01% 471
2013
Q2
$645K Buy
+11,026
New +$664K 0.01% 435

Other funds holding CELG

Bessemer Group's CELG Position: Q4 2019 in Review

Bessemer Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,939 shares — an estimated $589K sold.

Bessemer Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.71M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bessemer Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bessemer Group sold 5,939 Celgene Corp shares in Q4 2019, an estimated $589K.
  • Bessemer Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bessemer Group's Celgene Corp position peaked at $3.71M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bessemer Group's 13F filing for Q4 2019, filed 4 Feb 2020.